Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Figure 1
Blood glucose (a) and plasma insulin (b) concentrations during IV infusion of GLP-1, at 0.3 and 0.9 pmol/kg/minutes, or 0.9% saline, in 10 healthy humans. Data are means ± SEM. *GLP-1 0.3 and 0.9 versus saline: ; #GLP-1 0.9 versus GLP-1 0.3: (adapted from Little et al. 2006 [19], and used with permission from the publisher).
